We included only YAP1-responsive genes shown to represent bona fide targets by overlap in promoter occupancy via ChIP-seq and altered gene expression resulting from gain or loss of function studies in cardiomyocytes and SF268 glioblastoma cells21, 22 (Supplementary Data 2). This evidence concerns the gene YAP1 and glioblastoma.